{"id":"https://openalex.org/W4362594928","doi":"https://doi.org/10.1158/1538-7445.am2023-4946","title":"Abstract 4946: TOS-358, a first-in-class covalent PI3K\u03b1 inhibitor, demonstrates superior efficacy and does not induce significant hyperglycemia at efficacious doses in multiple animal models","display_name":"Abstract 4946: TOS-358, a first-in-class covalent PI3K\u03b1 inhibitor, demonstrates superior efficacy and does not induce significant hyperglycemia at efficacious doses in multiple animal models","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362594928","doi":"https://doi.org/10.1158/1538-7445.am2023-4946"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-4946","doi":"https://doi.org/10.1158/1538-7445.am2023-4946","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-4946","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086899527","display_name":"John R. MacDougall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John R. MacDougall","raw_affiliation_strings":["1Totus Medicines Inc., Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Totus Medicines Inc., Emeryville, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Bradley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Bradley","raw_affiliation_strings":["1Totus Medicines Inc., Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Totus Medicines Inc., Emeryville, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Raymond Mak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond Mak","raw_affiliation_strings":["1Totus Medicines Inc., Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Totus Medicines Inc., Emeryville, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008694190","display_name":"Neil S. Dhawan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil Dhawan","raw_affiliation_strings":["1Totus Medicines Inc., Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Totus Medicines Inc., Emeryville, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100655799","display_name":"Wei Chen","orcid":"https://orcid.org/0000-0001-6048-1860","observed_orcids":["https://orcid.org/0000-0001-6048-1860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Chen","raw_affiliation_strings":["1Totus Medicines Inc., Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Totus Medicines Inc., Emeryville, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"4946","last_page":"4946"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3kalpha-inhibitor","display_name":"PI3K\u03b1 inhibitor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/covalent-inhibition","display_name":"covalent inhibition","score":0.8029999732971191},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9279999732971191},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9020000100135803},{"id":"https://openalex.org/keywords/insulin-signaling","display_name":"insulin signaling","score":0.7929999828338623},{"id":"https://openalex.org/keywords/glucose-homeostasis","display_name":"glucose homeostasis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pi3k-isoform-selectivity","display_name":"PI3K isoform selectivity","score":0.6859999895095825},{"id":"https://openalex.org/keywords/tumor-models","display_name":"tumor models","score":0.328000009059906},{"id":"https://openalex.org/keywords/drug-safety-profile","display_name":"drug safety profile","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8327063322067261},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.564109742641449},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.5540857315063477},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4469175934791565},{"id":"https://openalex.org/C182704531","wikidata":"https://www.wikidata.org/wiki/Q1364740","display_name":"Knockout mouse","level":3,"score":0.4146284759044647},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41186007857322693},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.411316841840744},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38286787271499634},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35528478026390076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2694404721260071},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22941309213638306},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.22876518964767456},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15876087546348572}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-4946","doi":"https://doi.org/10.1158/1538-7445.am2023-4946","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-4946","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402560071","https://openalex.org/W4396587389","https://openalex.org/W4409413915","https://openalex.org/W4403648466","https://openalex.org/W4407767228","https://openalex.org/W4307911380","https://openalex.org/W2053661826","https://openalex.org/W6960147017","https://openalex.org/W4214611260","https://openalex.org/W4365512166"],"abstract_inverted_index":{"Abstract":[0],"PI3K\u03b1":[1,35,52,77,89,120,133,169,197],"is":[2,27,37],"frequently":[3],"mutated":[4],"in":[5,20,39,42,62,105,154,211],"a":[6,18,28,63,155,194],"variety":[7,64],"of":[8,34,65,144,151,168,218],"cancer":[9,91],"types,":[10],"and":[11,23,36,49,54,80,86,108,164,175,202,231],"the":[12,152,219],"PI3K-AKT":[13],"signaling":[14,22],"axis":[15],"also":[16,96],"plays":[17],"role":[19],"insulin":[21],"glucose":[24],"homeostasis.":[25],"TOS-358":[26,47,68,98],"highly":[29,162],"selective":[30],"first-in-class":[31,195],"covalent":[32,166,196],"inhibitor":[33],"currently":[38],"clinical":[40],"development":[41],"multiple":[43,145,212],"solid":[44],"malignancies.":[45],"Interestingly,":[46],"potently":[48],"specifically":[50],"inhibits":[51],"deeply":[53],"durably,":[55],"but":[56],"does":[57,99,122,203],"not":[58,100,123,204],"induce":[59,101,124,205],"significant":[60,102,125,206],"hyperglycemia":[61,103,138,207],"animal":[66,213],"models.":[67,92,214],"has":[69],"consistently":[70],"demonstrated":[71],"superior":[72,173,200],"efficacy":[73,174,201],"comparing":[74],"to":[75,136,140,171],"reversible":[76,132],"inhibitors":[78,134],"(ATP-competitive":[79],"Allosteric)":[81],"across":[82],"30+":[83],"different":[84],"PDX":[85],"CDX":[87],"mutant":[88],"dependent":[90],"Detailed":[93],"metabolic":[94],"studies":[95],"revealed":[97],"effects":[104],"mice,":[106],"rats":[107],"dogs":[109],"at":[110,148,208],"efficacious":[111,209],"doses,":[112],"which":[113],"mirrors":[114],"previous":[115,131],"finding":[116],"that":[117,119,130,161],"show":[118],"knockout":[121],"hyperglycemia.":[126],"Furthermore,":[127],"we":[128],"elucidate":[129],"lead":[135],"dramatic":[137],"due":[139],"their":[141],"potent":[142,165],"inhibition":[143,167],"PI3K":[146],"isoforms":[147],"effective":[149],"concentrations":[150],"molecules":[153],"cellular":[156],"setting.":[157],"This":[158],"data":[159],"reveals":[160],"specific":[163],"leads":[170],"dramatically":[172],"an":[176],"improved":[177],"safety":[178],"profile.":[179],"Citation":[180],"Format:":[181],"John":[182,185],"R.":[183],"MacDougall,":[184],"Bradley,":[186],"Raymond":[187],"Mak,":[188],"Neil":[189],"Dhawan,":[190],"Wei":[191],"Chen.":[192],"TOS-358,":[193],"inhibitor,":[198],"demonstrates":[199],"doses":[210],"[abstract].":[215],"In:":[216],"Proceedings":[217],"American":[220],"Association":[221],"for":[222],"Cancer":[223,242],"Research":[224],"Annual":[225],"Meeting":[226],"2023;":[227],"Part":[228],"1":[229],"(Regular":[230],"Invited":[232],"Abstracts);":[233],"2023":[234],"Apr":[235],"14-19;":[236],"Orlando,":[237],"FL.":[238],"Philadelphia":[239],"(PA):":[240],"AACR;":[241],"Res":[243],"2023;83(7_Suppl):Abstract":[244],"nr":[245],"4946.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-04-06T00:00:00"}